Osteoimmunology is an interdisciplinary field that explores the intricate interactions between the skeletal and immune systems. It focuses on the bidirectional communication between bone and immune cells, emphasizing the influence of the immune system on bone homeostasis and vice versa. Key players in osteoimmunology include osteoclasts, responsible for bone resorption, and osteoblasts, involved in bone formation. Immune cells, particularly T cells, B cells, and cytokines, play critical roles in regulating bone remodeling processes. Inflammatory conditions, such as rheumatoid arthritis and osteoporosis, underscore the dynamic relationship between the immune and skeletal systems. Chronic inflammation can lead to bone loss, while alterations in bone density can impact immune cell function. Understanding osteoimmunology has implications for developing therapies targeting both bone and immune disorders. Research in this field aims to uncover the molecular mechanisms governing these interactions, identify potential therapeutic targets, and advance treatment strategies for diseases involving both the skeletal and immune systems.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States